BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20621385)

  • 1. Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma.
    Seki N; Takasu T; Sawada S; Nakata M; Nishimura R; Segawa Y; Shibakuki R; Hanafusa T; Eguchi K
    Lung Cancer; 2010 Dec; 70(3):329-34. PubMed ID: 20621385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
    Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
    Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
    Salehi Z; Mashayekhi F
    Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
    Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH
    Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
    Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
    Alain T; Morita M; Fonseca BD; Yanagiya A; Siddiqui N; Bhat M; Zammit D; Marcus V; Metrakos P; Voyer LA; Gandin V; Liu Y; Topisirovic I; Sonenberg N
    Cancer Res; 2012 Dec; 72(24):6468-76. PubMed ID: 23100465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.
    Khoury T; Alrawi S; Ramnath N; Li Q; Grimm M; Black J; Tan D
    Clin Lung Cancer; 2009 Jan; 10(1):58-66. PubMed ID: 19289374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size.
    Eguchi S; Tokunaga C; Hidayat S; Oshiro N; Yoshino K; Kikkawa U; Yonezawa K
    Genes Cells; 2006 Jul; 11(7):757-66. PubMed ID: 16824195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
    Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
    Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
    Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
    Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.
    Diab-Assaf M; Abou-Khouzam R; Saadallah-Zeidan N; Habib K; Bitar N; Karam W; Liagre B; Harakeh S; Azar R
    Int J Clin Exp Pathol; 2015; 8(1):404-13. PubMed ID: 25755728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
    Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
    J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
    Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
    EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural scaffold for eIF4E binding selectivity of 4E-BP isoforms: crystal structure of eIF4E binding region of 4E-BP2 and its comparison with that of 4E-BP1.
    Fukuyo A; In Y; Ishida T; Tomoo K
    J Pept Sci; 2011 Sep; 17(9):650-7. PubMed ID: 21661078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
    Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
    Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma.
    Chen YT; Tsai HP; Wu CC; Wang JY; Chai CY
    Pathol Res Pract; 2017 May; 213(5):490-495. PubMed ID: 28242042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-terminal region of eIF4E and Ser65-phosphorylation of 4E-BP1 on interaction between eIF4E and 4E-BP1 fragment peptide.
    Tomoo K; Abiko F; Miyagawa H; Kitamura K; Ishida T
    J Biochem; 2006 Aug; 140(2):237-46. PubMed ID: 16825247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human eIF4E by 4E-BP1: binding analysis using surface plasmon resonance.
    Youtani T; Tomoo K; Ishida T; Miyoshi H; Miura K
    IUBMB Life; 2000 Jan; 49(1):27-31. PubMed ID: 10772338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L; Magagnin MG; Cleven AH; Weppler SA; Grenacher B; Landuyt W; Lieuwes N; Lambin P; Gorr TA; Koritzinsky M; Wouters BG
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1219-27. PubMed ID: 19251093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of protein synthesis by inducible wild-type p53 in human lung carcinoma cells.
    Tilleray V; Constantinou C; Clemens MJ
    FEBS Lett; 2006 Mar; 580(7):1766-70. PubMed ID: 16504179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.